Rituximab doses tested for blistering skin disease
NCT ID NCT07457944
First seen Mar 20, 2026 · Last updated Apr 24, 2026 · Updated 3 times
Summary
This study looked at how well different doses of rituximab work for people with pemphigus, a serious skin condition that causes blisters. Researchers tracked 275 patients to see if the drug helped control the disease and prevent relapses. The goal was to find the best dose to manage symptoms and reduce side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEMPHIGUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Dermatology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.